Focus on Anticoagulation Care

Back to articles

LMWH bridge therapy for warfarin patients: Is it needed?

KEY POINT

In patients with atrial fibrillation (AF) who stop chronic warfarin because of an invasive procedure, forgoing anticoagulation bridging was noninferior to bridging with low–molecular weight heparin (LMWH) for the prevention of arterial thromboembolism, according to results of a recent trial in the New England Journal of Medicine

SOURCES

Douketis J et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373:823–33.